OPA1 and mitochondrial disease: In addition to the two widely-studied mitochondrial proteins OPA1 and MFN2, mutations in SLC25A46 have also been identified as a pathogenic cause in a spectrum of neurological and mitochondrial diseases [5,8,11,17,18].